ArticleOncotarget2014

AMACR amplification and overexpression in primary imatinib-naïve gastrointestinal stromal tumors: a driver of cell proliferation indicating adverse prognosis.

Chien-Feng Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.